NEWSROOM

131 results have been found

Corporate
Investors
Products

2020
2019
2018
2017
2016

Order by: Newest A-Z

May 7, 2020

Grifols reinforces its liquidity position to EUR 1,700 million

May 7, 2020

Grifols Procleix Panther System with Automation Ready Technology (ART) receives FDA Approval

May 5, 2020

Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus

April 28, 2020

Grifols launches new 3-mL (900-IU) vial for high-potency HyperRAB^® (rabies immune globulin [human])

April 21, 2020

Grifols maintains its operational levels and continues to reinforce its commitment to society

Content: footer-organization-info

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.